These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20592323)

  • 21. Topiramate in migraine prevention.
    Silberstein SD
    Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study of topiramate dosages for migraine prophylaxis in an Asian population.
    Lo YL; Lum SY; Fook-Chong S; Siow HC
    J Headache Pain; 2010 Apr; 11(2):175-8. PubMed ID: 20143246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute psychotic disorders induced by topiramate: report of two cases.
    Stella F; Caetano D; Cendes F; Guerreiro CA
    Arq Neuropsiquiatr; 2002 Jun; 60(2-A):285-7. PubMed ID: 12068361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.
    Ashtari F; Shaygannejad V; Akbari M
    Acta Neurol Scand; 2008 Nov; 118(5):301-5. PubMed ID: 18713156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Psychosis with topiramate].
    García Cabeza I; Gutiérrez Rodríguez M; Epifanio Gutiérrez MM
    Actas Esp Psiquiatr; 2000; 28(3):202-4. PubMed ID: 11000703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Topiramate in the preventive treatment of migraine: experience in a tertiary center].
    Krymchantowski AV; Tavares C; Penteado Jd Jde C; Adriano M
    Arq Neuropsiquiatr; 2004 Mar; 62(1):91-5. PubMed ID: 15122440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topiramate monotherapy in epilepsy and migraine prevention.
    Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F
    Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychosis following treatment with topiramate].
    Voskuil PH
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):319-20; author reply 320. PubMed ID: 12622013
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypomania complicating topiramate therapy for migraine prophylaxis.
    Okuyucu E; Melek IM; Duman T; Tunç T
    Eur J Neurol; 2007 Mar; 14(3):e6. PubMed ID: 17355539
    [No Abstract]   [Full Text] [Related]  

  • 32. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD; Neto W; Schmitt J; Jacobs D;
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migraine and topiramate induced dyspnea.
    Delpirou-Nouh C; Gelisse P; Chanez P; Carlander B
    Headache; 2007; 47(10):1453-5. PubMed ID: 17868349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder.
    Andrade C
    Bipolar Disord; 2001 Aug; 3(4):211-2. PubMed ID: 11552960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.
    Villani V; Ciuffoli A; Prosperini L; Sette G
    Headache; 2011 Feb; 51(2):287-91. PubMed ID: 21284610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the ability of topiramate to improve the daily activities of patients with migraine.
    Brandes JL; Kudrow DB; Rothrock JF; Rupnow MF; Fairclough DL; Greenberg SJ
    Mayo Clin Proc; 2006 Oct; 81(10):1311-9. PubMed ID: 17036556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.